The Wait Is Over – Discover the First BTKi for nrSPMS in the UAE: Cenrifki® Be part of an exclusive session unveiling a breakthrough in nrSPMS management —Cenrifki® (Tolebrutinib), advancing efficacy and safety in relapsing nrSPMS. Discover clinical insights and practical perspectives from leading experts. Watch the launch video now!
376 Reached
Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes
Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes
Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes
Headache with Clinically Non-functioning Pituitary Adenoma
818 Reached1 Comments4 Likes
OSA in Child
597 Reached3 Comments2 Likes